18th Annual 2023 Spring Advances in Neurology - May 13, 2023

The 18th annual Advances in Neurology course hosted by the University of Louisville Department of Neurology. This year’s focus will include updates on all subspecialties in neurology from local, regional, and nationally recognized experts in the field.
When May 13, 2023
from 08:30 AM to 04:00 PM
Where UofL Shelby Campus, 440 N Whittington Pkwy, Louisville, KY 40222
Contact Name
Contact Phone 502-852-3285
Add event to calendarvCal
iCal

 

Target Audience
Physicians, Nurse Practitioners, Nurses, Allied Health Professionals, Residents and Students.

Agenda
Saturday, May 13, 2023

8:30 AM - 9:00 AM
Intro/Poster Session    

9:00 AM - 9:45 AM
Palliative Care - Palliative Medicine for the Neurology Patient
Edward Dunn, MD

9:45 AM - 10:30 AM
Addiction Medicine - Straddling the fence of treatment versus harm reduction in addiction
Christopher Stewart, MD

10:30 AM - 11:15 AM
Epilepsy - Preventing System Failure of the Matrix Through Epilepsy Quality Improvement Projects
Meriem K Bensalem-Owen, MD

11:15 AM - 12:00 PM
Movement Disorders - Non-motor features of PF
Peter Hedera, MD

12:00 PM - 1:00 PM
Lunch Break    

1:00 PM - 1:45 PM
Neuroimmunology - Therapeutic Advances in Multiple Sclerosis
Gopika Kutty, MD

1:45 PM - 2:30 PM
Autonomic Nervous System - Autonomic Disorders: It's All in the Numbers
Amanda Peltier, MD

2:30 PM - 3:15 PM
Headache - Advances in Acute and Preventive Treatment of Migraine
Michael Sowell, MD

3:15 PM
Adjourn

Course Directors
 Vishwanath Sagi, MD

Assistant Professor
Assistant Clerkship Director
Department of Neurology
University of Louisville


 Michael Sowell, MD
Professor of Neurology
Associate Professor of Pediatrics
Assistant Program Director, Child Neurology Residency Program
Director, Comprehensive Headache Program
University of Louisville


Participating Faculty
Edward Dunn, MD
Associate Professor of Medicine
Division of General Internal Medicine, Palliative Medicine & Medical Education
University of Louisville

Peter Hedera, MD
Department of Neurology
Movement Disorders Division
University of Louisville

Gopika Kutty, MD
Fellow in Department of Neurology
Ohio State University

Meriem Bensalem-Owens, MD
Director, Epilepsy Program
Kentucky Neuroscience Institute
University of Kentucky

Amanda Peltier, MD
Professor of Neurology
Vanderbilt University

Christopher Stewart, MD
Psychiatrist
Associate Professor
Director of Addictions Program
Addictions Fellowship Training Director
UofL Health Care Outpatient Center

Learning Objectives

As a result of participating in this activity, participants should be able to:
1) Identify the appropriate prescribing of newer treatments in migraine headache.  
2) Identify the recognition and management of movement disorders.
3) Develop knowledge of the newer antiseizure medication options
4) Evaluate and manage recent substance use disorders.
5) Describe the newer available treatments of multiple sclerosis.
6) Appropriately recognize, evaluate, and manage autonomic nervous system disorders.
7) Discuss the currently available best practices in palliative care.

Continuing Education Credit
 Physician Credit
- The University of Louisville Continuing Medical Education office designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses - This program has been approved by the Kentucky Board of Nursing for 6.3 continuing education credits through University of Louisville Hospital, provider number 4-0068-12-24-1336. The Kentucky Board of Nursing approval of an individual nursing education provider does not constitute endorsement of program content. Completion criteria to obtain CE's: Attend entire session and complete the evaluation.

Accreditation
 The University of Louisville School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Special Services

All individuals are encouraged to participate. To request disability arrangements, please contact  , at (502) 852-3285 at least 14 days prior to the date of this program. Continuing Medical Education and Professional Development fully complies with the legal requirements of the ADA and the rules and regulations thereof.


Brochure

CLICK HERE for a copy of the course brochure

The Commonwealth Neurological Society (CNS) is the state neurology society for Kentucky. We are the organized voice of neurology to our national organization, as well as the liason with the American Medical Association, Kentucky Medical Association, and other interested parties in health care.  As such, we are best positioned to advocate for the needs of patients with neurological disorders in the Commonwealth.  We have developed a vital and growing network of neurologists and associated professionals that will benefit our practices and our patients.

Registration
There is no charge for this continuing education event. Advance registration is required.

In-person Conference
CLICK HERE to Register for this Conference

Live Webinar
CLICK HERE to Register for the Webinar version of this Conference

An email will be sent to all registrants 1 week prior and again 2 days prior with instructions for webinar sign-in.

Acknowledgments
We thank our supporting and exhibiting companies for their participation in the 2023 Spring Advances in Neurology symposium. A final listing of supporters and exhibitors will be available at the webinar.

Accreditation Disclosure
As a provider accredited by the ACCME, the Office of CME&PD, School of Medicine, University of Louisville, must ensure balance, independence, objectivity, and scientific rigor in all its accredited educational activities. All Planners, faculty, reviewers, and other persons that affected the content of this CME activity were required to submit a financial disclosure form from which relevant conflicts of interest were determined. If any relevant financial relationship(s) with ineligible companies were disclosed, the materials each of them prepared for this program (or influenced) were peer-reviewed and determined to be without ineligible company bias, were considered fair and balanced in terms of therapeutic options, and presented evidence-based content. All relevant financial relationships with ineligible organizations have been mitigated prior to this activity.

Learner Consent Statement
Names or contact information of learners will not be shared with any ineligible company or its agents without the explicit consent of the individual learner.